✦ LIBER ✦

Health-related quality of life in patients with pharyngeal carcinoma: A five-year follow-up

✍ Scribed by Mats Nordgren; Magnus Jannert; Morten Boysen; Marianne Ahlner-Elmqvist; Ewa Silander; Kristin Bjordal; Eva Hammerlid

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 402 KB
Volume: 28
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.20334

No coin nor oath required. For personal study only.

✦ Synopsis

Purpose:

The purpose was to evaluate the health-related quality of life (hrql) of patients with pharyngeal carcinoma at diagnosis and after 1 and 5 years in relation to tumor location and treatment modality in a prospective multicenter study.

Methods:

Eighty-nine patients with pharyngeal carcinoma (mean age, 60.0 years; 76% men) were evaluated using the european organization for research and treatment of cancer quality of life questionnaire-core 30 (eortc qlq-c30) and the european organization for research and treatment of cancer quality of life questionnaire head and neck cancer module (eortc qlq-h&n35).

Results:

Problems with dry mouth and teeth became worse between diagnosis and the 5-year follow-up. problems with thick secretions and teeth increased between 1 and 5 years. the hrql at diagnosis was associated with survival. patients with oropharyngeal carcinoma reported better hrql than patients with hypopharyngeal carcinoma.

Conclusions:

For patients with pharyngeal carcinoma, the hrql at diagnosis seems to be an important factor for the prognosis of both hrql over time and survival. treatment of pharyngeal carcinoma often results in long-term side effects such as dry mouth, problems with teeth, and thick secretions.

📜 SIMILAR VOLUMES

Five-year follow-up of health-related qu

Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer

✍ Ida J. Korfage; Marie-Louise Essink-Bot; Gerard J.J.M. Borsboom; Joanna B. Madal 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 114 KB 👁 1 views

## Abstract Although with earlier detection of prostate cancer more men face the long‐term consequences of primary treatment, studies on the impact of treatment on long‐term health‐related quality of life (HRQoL) are scarce. We followed 314 men with newly diagnosed localized prostate cancer from 1

Five-year follow-up of oral functioning

Five-year follow-up of oral functioning and quality of life in patients with oral cancer with implant-retained mandibular overdentures

✍ Anke Korfage; Pieter J. Schoen; Gerry M. Raghoebar; Jelte Bouma; Fred R. Burlage 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract ## Background The purpose of this prospective study was to assess the quality of life (QOL) and oral functioning of patients with oral cancer up to 5 years after prosthodontic rehabilitation with mandibular implant‐retained overdentures. ## Methods Fifty patients who had received imp

Health related quality of life in prosta

✍ Fabio Efficace; Andrew Bottomley; George van Andel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

## Abstract ## BACKGROUND Health related quality of life (HRQOL) is increasingly reported as an important endpoint in cancer clinical trials. However, evidence suggests that HRQOL reporting is often inadequate. Given this, the authors undertook a systematic review to evaluate HRQOL assessment meth

Impact of functional support on health-r

Impact of functional support on health-related quality of life in patients with colorectal cancer

✍ Shahnaz Sultan; Deborah A. Fisher; Corrine I. Voils; Anita Y. Kinney; Robert S. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

Health-related quality of life in patien

✍ Michael Walsh; Chetan Mukhtyar; Alfred Mahr; Karen Herlyn; Raashid Luqmani; Pete 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 108 KB 👁 2 views

Sustained improvement of health-related

Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years

✍ Francesc Casellas; Luis Rodrigo; Pilar Niño; Carmen Pantiga; Sabino Riestra; Jua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 1 views

## Background: Infliximab induces remission and improves the health-related quality of life (hrqol) of patients with refractory or fistulous crohn's disease (cd). however, little information is available as to whether its effect on hrqol is sustained over time. the objective was to measure the hrqo